How the COVID-19 Pandemic Changed Cellular Therapy at Columbia University Irving Medical Center/NewYork-Presbyterian Hospital

Transfusion. 2020 Jun 24. doi: 10.1111/trf.15956. Online ahead of print.

Abstract

New York is at the epicenter of the coronavirus disease 2019 (COVID-19) pandemic caused by the SARS-CoV-2 virus. Columbia University Irving Medical Center/NewYork-Presbyterian Hospital (CUIMC/NYPH) had to make changes to its cellular therapy operations to ensure patient, donor, and staff safety and well-being. In this article, we discuss the process changes we instituted for cellular therapy clinical care, collection, processing, and cryopreservation to cope with the rapidly evolving pandemic.